<DOC>
	<DOCNO>NCT00095212</DOCNO>
	<brief_summary>Androgen deficiency HIV-infected woman associate sarcopenia may cause critical reduction physical functioning reduce bone density . The effect long-term androgen therapy lean body mass , bone density clinical endpoint include quality life , functional status neurocognitive function HIV-infected woman know .</brief_summary>
	<brief_title>Androgen Effects HIV-infected Women</brief_title>
	<detailed_description>We perform 18-month randomize , double-blinded , placebo-controlled study among relatively androgen deficient woman HIV , determine effect testosterone administration lean body mass . The administer dose 300 microgram twice week vs. identical placebo form transdermal preparation . Secondary endpoint include effect bone density , quality life , neurocognitive function menstrual function . Open label administration 300 microgram twice week initiated 12 month subject follow randomized portion study . Assuming 15 % dropout rate 25 randomized patient , probability 80 percent study detect treatment difference two side 5.000 percent significance level , true difference treatment 2.7 kg . This base assumption standard deviation response variable , lean body mass DEXA , 2.3 kg , show Choi et al1 12 week HIV-infected woman dose 300 ug 2x/week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Female 18 55 BMI less equal 26 HIVinfected Androgen deficient , free testosterone &lt; 3 pg/mL Stable antiretroviral regimen 3 month prior study Tubal ligation , hysterectomy , verbalize understanding appropriate barrier contraception method . Subjects counsel appropriate barrier contraception method counsel document . Use anabolic agent , include testosterone , GH preparation within 3 month study . Use megestrol acetate within 3 month study Use estrogen preparation know affect bone density bone turnover.This include oral contraceptive , depo provera combine progesteroneestrogen injection , transdermal contraceptive patch . Pregnant breastfeed Hgb &lt; 9.0 mg/dL Current participation another research study conduct investigator past participation DHEA study fund grant protocol . Creatinine &gt; 1.5 mg/dL</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>HIV</keyword>
	<keyword>woman</keyword>
	<keyword>androgen</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>